News – Page 875 – Endpoints News

Doudna-founded CRISPR upstart bags $45M for new Cas research, extends its reach into therapeutics

6 years ago

With deals in tow, Roche ends 2019 with five discarded programs

6 years ago

The second, first AI developed drug enters the clinic; Aprea gets breakthrough status for myelodysplastic syndromes ...

6 years ago

Vas Narasimhan wants Novartis to have a big focus on China. Here’s what that looks like

6 years ago

Eli Lilly notches another positive baricitinib eczema trial, but has Dermira made it obsolete?

6 years ago

Josh Bilenker’s team at Eli Lilly chops 3 cancer drug programs in pipeline cleanup as their $1.6B IL-10 effort ...

6 years ago

FDA outlines product development process to combat Wuhan coronavirus

6 years ago

Rani Therapeutics eyes potential IPO as robotic pill technology takes shape

6 years ago

Sanofi polishes rare disease profile as Niemann-Pick drug scores promising PhII/III data — there's just one ...

6 years ago

Cancer-focused Black Diamond vaults on to Nasdaq in $200M+ public debut, marking biggest biotech IPO in 2020 so far

6 years ago

'What's he going to do? He's going to date his wife more!' Steve Holtzman on Decibel and leaving biotech (again)

6 years ago

The first drug from Eli Lilly's new-look oncology group gets speedy review as Bilenker's team hones focus

6 years ago

Sanofi stops all but the most urgent trips to China; Flurry of orphan drug designations arrive

6 years ago

Novartis rethinks CML strategy for next-gen allosteric drug due for a pivotal readout later this year

6 years ago

What in the world is a MINOR CRL, Amphastar?

6 years ago

Patient dies in a troubled HBV drug program — forcing developers to scrap the drug and shift focus. To STING

6 years ago

Putting buybacks on hold, Pfizer’s CEO is plotting a string of important PhII deals in the year ahead. You’ve ...

6 years ago

How do American scientists get embroiled in China scandals? Moffitt investigation sheds some light

6 years ago

Laurence Reid returns as CEO of Decibel Therapeutics — as Steve Holtzman retires

6 years ago

Ionis/Akcea's Pfizer-partnered antisense drug shows promise in study, with implications for Arrowhead RNAi asset ...

6 years ago

Following a NASH crash, Conatus turns the keys over to regenerative med player

6 years ago

Top Harvard chemist caught up in FBI’s 'Thousand Talents' dragnet, accused of lying about Chinese connections, pay

6 years ago

Eyeing a trio of trial initiations, Jim Wilson's gene therapy startup woos Bruce Goldsmith from Deerfield as CEO

6 years ago

Flagship's first venture of 2020 is out, and it's all about sperm

6 years ago

First page Previous page 872 873 874875876 877 878 Next page Last page